Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Almirall
Explore 17 clinical trials worldwide
Search
Showing 1-17 of 17 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Almirall
Clinical Trials (17)
NCT07151937
A Study of LAD191 in Adults With Hidradenitis Suppurativa
PHASE2
Not yet recruiting
200 participants
Started: Sep 30, 2025 · Completed: Nov 30, 2027
1 condition
1 sponsor
0 locations
NCT06928246
The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
PHASE1
Recruiting
8 participants
Started: Jul 17, 2025 · Completed: Jan 31, 2026
1 condition
2 sponsors
2 locations
NCT06906497
Lebrikizumab in Moderate-to-severe Atopic Dermatitis
PHASE4
Recruiting
48 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2027
1 condition
3 sponsors
4 locations
NCT06923202
Study of Alloknesia in Atopic Dermatitis
N/A
Not yet recruiting
160 participants
Started: Apr 30, 2025 · Completed: May 1, 2026
2 conditions
2 sponsors
0 locations
NCT06815380
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
N/A
Recruiting
1,000 participants
Started: Jan 23, 2025 · Completed: Mar 31, 2029
2 conditions
1 sponsor
1 location
NCT06526182
A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
PHASE3
Recruiting
520 participants
Started: Jul 3, 2024 · Completed: Apr 30, 2027
2 conditions
1 sponsor
4 locations
NCT06488170
A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting
N/A
Active, not recruiting
42 participants
Started: Apr 4, 2024 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT06200597
A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects
PHASE1
Recruiting
92 participants
Started: Dec 5, 2023 · Completed: Mar 11, 2025
1 condition
1 sponsor
1 location
NCT05990725
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
PHASE3
Active, not recruiting
240 participants
Started: Nov 20, 2023 · Completed: Jun 23, 2025
2 conditions
1 sponsor
33 locations
NCT06029257
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
N/A
Recruiting
110 participants
Started: Nov 14, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06030076
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
N/A
Recruiting
50 participants
Started: Sep 6, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05916365
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
PHASE3
Active, not recruiting
200 participants
Started: May 23, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
32 locations
NCT06032403
Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations
NA
Active, not recruiting
200 participants
Started: Jan 31, 2023 · Completed: Aug 31, 2025
1 condition
6 sponsors
1 location
NCT05387525
A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
PHASE4
Active, not recruiting
447 participants
Started: Oct 24, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
49 locations
NCT06488209
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
PHASE1
Recruiting
72 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
3 locations
NCT02075697
Spanish Registry of Systemic Treatments in Psoriasis
N/A
Recruiting
3,500 participants
Started: Oct 31, 2008 · Completed: Oct 31, 2025
1 condition
14 sponsors
13 locations
NCT01848028
PsoBest - The German Psoriasis Registry
N/A
Recruiting
3,500 participants
Started: Jan 31, 2008 · Completed: Dec 31, 2032
2 conditions
20 sponsors
1 location